|
|
Volumn 23, Issue 30, 2005, Pages 7397-7398
|
|
Cancer vaccines: The role of tumor burden in tipping the scale toward vaccine efficacy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
HER 2 PEPTIDE E75 (369 377), HUMAN;
HER-2 PEPTIDE E75 (369-377), HUMAN;
PEPTIDE FRAGMENT;
ACTIVE IMMUNIZATION;
ADVANCED CANCER;
ANTIGEN SPECIFICITY;
BREAST CANCER;
CANCER RELAPSE;
CANCER STAGING;
CELL MIGRATION;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TARGETING;
EDITORIAL;
ENZYME LINKED IMMUNOSPOT ASSAY;
HUMAN;
IMMUNE RESPONSE;
ONCOGENE NEU;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TREATMENT RESPONSE;
TUMOR VOLUME;
BREAST TUMOR;
FEMALE;
IMMUNOLOGY;
NOTE;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
CANCER VACCINES;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
PEPTIDE FRAGMENTS;
|
|
EID: 32944465998
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.07.020 Document Type: Editorial |
|
Times cited : (21)
|
|
References (7)
|
